AAM Statement on Generic Drugs in Medicare Part D. Trends in Tier Structure and Placement, Avalere Health, May 22, 2018:
“In 2015, patients spent more than $6 billion in additional out-of-pocket costs on generic drugs compared to 2011. These increased out-of-pocket expenses on low-cost generics are being used by the plans to mask increases in branded drug prices.”
Avalere Health study funded by Association for Accessible Medicines.
ATTRIBUTE TO: Chip Davis, AAM President and CEO
Press Release
MEDIA CONTACT:
Rachel Schwartz
202.249.7147 (o)
202.251.8881 (c)
Issues